Fenofibrate Exerts Protective Effects in Diabetic Retinopathy

Area of Science:

• Ophthalmology
• Endocrinology
• Pharmacology

Background:

• Diabetic retinopathy is a leading cause of vision loss.
• Oxidative stress, inflammation, and impaired autophagy contribute to its pathogenesis.
• Ferroptosis has emerged as a critical cell death pathway in diabetic retinopathy.

Purpose of the Study:

• To investigate the protective effects of fenofibrate on retinal health in diabetic retinopathy.
• To evaluate fenofibrate's impact on oxidative stress, inflammation, autophagy, and ferroptosis.
• To assess fenofibrate's potential as a therapeutic agent for diabetic retinopathy.

Main Methods:

• A streptozotocin (STZ)-induced diabetic rat model was used.
• Cultured ARPE-19 cells under high glucose conditions were utilized.
• Key markers of oxidative stress, autophagy, and tight junction integrity were measured.

Main Results:

• Fenofibrate significantly reduced reactive oxygen species (ROS) production and NADPH oxidase activity.
• Autophagy was enhanced, evidenced by increased LC3 expression.
• Tight junction protein expression was maintained, contributing to cellular homeostasis.

Conclusions:

• Fenofibrate demonstrates significant protective effects against diabetic retinopathy.
• It mitigates oxidative stress and inflammation while promoting autophagy and inhibiting ferroptosis.
• Fenofibrate represents a promising therapeutic candidate for managing diabetic retinopathy.